Power Forward Study: A Cross-Sector, Multisite Clinical Trial of a Powered Knee-Ankle-Foot Orthosis

RecruitingNot a drug-phase studyMS (type not specified)NCT05644522

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Indego Nomad® Powered Knee-Ankle-Foot Orthosis (P-KAFO) (Parker Hannifin Corp., Cleveland, OH)

What it measured

Main measures

  • Change in 10 Meter Walk Test speed

    Baseline, Post 3-month home trials with each device

    Walking and mobility

Other measures (16)

  • Six Minute Walk Test

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Berg Balance Test

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Functional Gait Assessment

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Hill Assessment Index

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Stair Assessment Index

    Baseline, Post 3-month home trials with each device

  • Timed Up and Go

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Activities Specific Balance Confidence Scale

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Modified Falls Efficacy Scale

    Baseline, Post 3-month home trials with each device

    Walking and mobility
  • Orthotics and Prosthetics User Survey

    Baseline, Post 3-month home trials with each device

  • World Health Organization Quality of Life

    Baseline, Post 3-month home trials with each device

    Quality of life (reported by participants)

Who could take part

MS (type not specified) · 18 to 89

Show the full criteria

Inclusion criteria

* Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma * Cognitive ability to understand and follow the study protocol; willingness to provide informed consent * Willing to wear and charge an activity monitor for three-months home trials.

Exclusion criteria

* Flexion contracture in the knee and/or hip joint in excess of 15 degrees * Non-correctable knee varus/valgus in excess of 15 degrees * Severe spasticity * Inability to stabilize the trunk with or without assistive devices (crutches, canes, etc.)

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: * Wear a sensor that records everyday activities and mobility. * Perform measures of mobility and different activities of participation using their own brace. * Perform measures of mobility and different activities of participation using the Nomad powered KAFO

Loading reviews and guidelines…

History

    1. Started

      Mar 2024

    2. Main results due

      Dec 2027

    3. Finished

      Dec 2027

    Assembled by software from public sources.